PAHC (STOCKS)
Phibro Animal Health Corporation Class A
$51.265000
-0.255000 (-0.49%)
Prev close: $51.520000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jack C. Bendheim
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,080.37M
- Employees
- 2,475
- P/E (TTM)
- 22.84
- P/B (TTM)
- 6.28
- Dividend Yield
- 93.17%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $1.46B |
| Benefits Costs and Expenses | $1.34B |
| Cost Of Revenue | $997.31M |
| Costs And Expenses | $1.34B |
| Gross Profit | $467.02M |
| Operating Expenses | $298.20M |
| Selling, General, and Administrative Expenses | $298.20M |
| Operating Income/Loss | $168.82M |
| Income/Loss From Continuing Operations After Tax | $92.09M |
| Income/Loss From Continuing Operations Before Tax | $126.23M |
| Income Tax Expense/Benefit | $34.14M |
| Net Income/Loss | $92.09M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $92.09M |
| Net Income/Loss Available To Common Stockholders, Basic | $92.09M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $2.27 |
| Diluted Earnings Per Share | $2.26 |
| Basic Average Shares | 81,060,000 |
| Diluted Average Shares | 81,634,000 |
| Assets | $1.41B |
| Current Assets | $862.19M |
| Inventory | $517.35M |
| Other Current Assets | $344.84M |
| Noncurrent Assets | $543.37M |
| Fixed Assets | $355.38M |
| Other Non-current Assets | $187.99M |
| Liabilities | $1.07B |
| Current Liabilities | $282.37M |
| Accounts Payable | $133.30M |
| Wages | $44.11M |
| Other Current Liabilities | $104.97M |
| Noncurrent Liabilities | $790.82M |
| Long-term Debt | $624.24M |
| Other Non-current Liabilities | $166.58M |
| Equity | $332.36M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $332.36M |
| Liabilities And Equity | $1.41B |
| Net Cash Flow From Operating Activities | $93.08M |
| Net Cash Flow From Operating Activities, Continuing | $93.08M |
| Net Cash Flow From Investing Activities | -$63.48M |
| Net Cash Flow From Investing Activities, Continuing | -$63.48M |
| Net Cash Flow From Financing Activities | -$42.63M |
| Net Cash Flow From Financing Activities, Continuing | -$42.63M |
| Exchange Gains/Losses | $1.45M |
| Net Cash Flow | -$11.59M |
| Net Cash Flow, Continuing | -$13.04M |
| Comprehensive Income/Loss | $103.89M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $103.89M |
| Other Comprehensive Income/Loss | $32.68M |
| Other Comprehensive Income/Loss Attributable To Parent | $11.80M |